FDA's decision to take a hands-off approach toward medical device servicing has left servicers and device makers at odds: Servicers praise the move, but device manufacturers are upset and say Congress must now step in to require at least some minimal level of federal oversight. FDA unveiled its stance in a report earlier this month that found there isn't enough data to support concerns that servicing poses a widespread public health concern, although the agency said device remanufacturing might pose...